Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies. | Biomolecules | 2025 | 40563438 | PubTator, text mining | PubMed |
| Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions. | Front Immunol | 2025 | 40510370 | PubTator, text mining | PubMed |
| Principles and functional consequences of plasmid chromatinization in mammalian cells. | bioRxiv | 2025 | 40501650 | PubTator, text mining | PubMed |
| Upregulation of miR-17-3p is associated with HbF in patients with β-thalassemia and induces γ-globin expression by targeting BCL11A. | Orphanet J Rare Dis | 2025 | 40448206 | PubTator, text mining | PubMed |
Genetic polymorphism of novel SNP rs5006884 in OR51B6 and SNP rs4499252 in AHSP among transfusion-dependent and non-transfusion-dependent β-thalassemia/Hb E patients in Thailand: a multivariate analysis of clinical and genetic polymorphism. | Ann Hematol | 2025 | 40377674 | PubTator, text mining | PubMed |
| A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes. | Blood | 2025 | 40332467 | PubTator, text mining | PubMed |
| CHD8 interacts with BCL11A to induce oncogenic transcription in triple negative breast cancer. | EMBO J | 2025 | 40328966 | PubTator, text mining | PubMed |
| Decoding HbF reactivation by hydroxyurea in hemoglobinopathy patients through microRNA signatures. | Ann Hematol | 2025 | 40278921 | PubTator, text mining | PubMed |
| Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach. | Pharmacogenomics J | 2025 | 40268903 | PubTator, text mining | PubMed |
| Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review. | Curr Res Transl Med | 2025 | 40252393 | PubTator, text mining | PubMed |
| Multimeric transcription factor BCL11A utilizes two zinc-finger tandem arrays to bind clustered short sequence motifs. | Nat Commun | 2025 | 40246927 | PubTator, text mining | PubMed |
| Rewriting regulatory DNA to dissect and reprogram gene expression. | Cell | 2025 | 40245860 | PubTator, text mining | PubMed |
| Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia. | Am J Hematol | 2025 | 40186439 | PubTator, text mining | PubMed |
| Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects. | Expert Rev Mol Med | 2025 | 40160040 | PubTator, text mining | PubMed |
| The future of ex vivo hematopoietic stem cell gene editing: what's next. | Regen Med | 2025 | 40137438 | PubTator, text mining | PubMed |
| Solution structure of the Z0 domain from transcription repressor BCL11A sheds light on the sequence properties of protein-binding zinc fingers. | Protein Sci | 2025 | 40099876 | PubTator, text mining | PubMed |
| A critique review of fetal hemoglobin modulators through targeting epigenetic regulators for the treatment of sickle cell disease. | Life Sci | 2025 | 40057227 | PubTator, text mining | PubMed |
| Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by Bioinformatic Analysis. | J Kidney Cancer VHL | 2025 | 40051609 | PubTator, text mining | PubMed |
| FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries. | Nat Commun | 2025 | 40025045 | PubTator, text mining | PubMed |
| BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice. | Blood Adv | 2025 | 40020162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=7